SNOA News & Events

Sonoma Pharmaceuticals announced the U.S. retail launch of its advanced HOCl-based burn relief hydrogel in CVS (CVS) and Walmart (WMT) stores nationwide. The hydrogel is indicated for the management of minor burns and skin irritations. This launch represents Sonoma's first large-scale consumer-focused burn relief product, building on the Company's established presence in professional healthcare settings, where its HOCl-based solutions have long been used in advanced wound and burn care protocols. Sonoma previously demonstrated its ability to translate clinically proven technologies into scalable consumer offerings through the launch of its diaper rash hydrogel in mass retail in 2025.

Sonoma Pharmaceuticals announced the launch of Aquanil AD, a hypochlorous acid based dermatology product line for sensitive skin, developed exclusively for Persundefinedn & Covey, Inc. for distribution through its established over-the-counter dermatology channels in the U.S. The Aquanil AD product line includes Aquanil AD Repair Mist, a soothing spray for irritated or damaged skin; Aquanil AD Recovery Gel, designed to help reduce the appearance of scars; and Aquanil AD Rescue Serum for relief from rashes, itching and irritation. Each product was specifically designed for sensitive or reactive skin.

Sonoma Pharmaceuticals announced that Reliefacyn Advanced Itch-Burn-Rash-Pain Relief Hydrogel has earned the National Rosacea Society Seal of Acceptance.

Reports Q2 revenue $5.6M vs. $3.6M last year. "We are thrilled to report the highest quarterly revenues in Sonoma's history - $5.6 million for the three months ended September 30, 2025," said Amy Trombly, CEO of Sonoma Pharmaceuticals. "This achievement reflects the exceptional work of our team in expanding our distribution network, launching new products, and obtaining key regulatory clearances. While we anticipate some quarterly fluctuations as we continue to grow, we expect Sonoma's overall trajectory to be strongly positive, with increasing adoption of our high-quality products by both consumers and healthcare providers and solidification of our position as the global leader in the HOCl industry."